PUNE, India, July 6, 2016 /PRNewswire/ --
Global fractional flow reserve market 2016 report says a trend which is propelling market growth is the rising number of clinical trials and regulatory approvals. There has been a growing trend of clinical trials and regulatory approvals in the market. With the growing demand for fractional flow reserve technology, the new companies are continuously seeking ways to gain approvals and launch new products in the market to improve their market share. In January 2014, ACIST's RXi received 510(k) FDA approval for use in gaining intravascular pressure measurements in the diagnosis and treatment of peripheral artery disease and CAD.
Complete report on fractional flow reserve market spread across 65 pages, analyzing 5 major companies and providing 38 data exhibits is now available at http://www.rnrmarketresearch.com/global-fractional-flow-reserve-market-2016-2020-market-report.html.
By 2020, the multi-vessel segment is expected to account for around 63% of the market to continue its dominion over the global the fractional flow reserve market. Fractional flow reserve measurement is critical for individuals suffering from multivessel disease, as it can wholly reshape the revascularization strategy. The more judicious use of stents during the treatment of myocardial ischemia in the procedure enhances the clinical outcome and decreases healthcare costs. For instance, myocardial perfusion scintigraphy is limited in accurately localizing lesions responsible for ischemia.
The analysts forecast global fractional flow reserve market to grow at a CAGR of 14.14% during the period 2016-2020. According to the 2016 flow reserve market report, a key growth driver is the increased need for diagnosis of coronary artery diseases (CAD). There has been an increased need for a suitable procedure to diagnose the growing prevalence of CAD. Coronary angiography is the standard procedure used for diagnosis of CAD. However, the standard coronary angiography with visual assessment and quantitative coronary angiography alone cannot accurately predict the exact lesion that is causing ischemia. These methods may not provide the clear picture about the severity and hemodynamic significance of lesions. Several studies state that the coronary angiogram is limited and does not measure the extent to which a stenosis is hampering the blood flow. Therefore, the demand for new diagnosis techniques such as fractional flow reserve has increased. Order a copy of Global Fractional Flow Reserve Market 2016-2020 report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=626350.
Recently, there has been an increase in clinical trials and regulatory approvals in the fractional flow reserve market. The growing demand for fractional flow reserve technology is prompting new companies in the market to develop products that are cost-effective. As a result, companies are constantly seeking ways to gain approvals and launch new products.
The following companies are the key players in the global fractional flow reserve market: ACIST, Boston Scientific, Opsens, St. Jude Medical, Volcano. Other prominent vendors in the market are: Abbott Laboratories, Asahi Intec, Biosensors, BIOTRONIK international, GE Healthcare, HeartFlow, McKesson, Mennen Medical, Siemens Healthcare, and Terumo.
Global Fractional Flow Reserve Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. The report covers the present scenario and the growth prospects of the global fractional flow reserve market for 2016-2020. Further, the report states that one challenge that could impact market growth adversely is the stringent regulatory environment.
Another related report is Global Vascular Stents Market 2016-2020; the analysts forecast global vascular stents market to grow at a CAGR of 7.38% during the period 2016-2020. According to the report, a key growth driver is the demand for minimally invasive procedures. Minimally invasive procedures involve smaller incisions. They help prevent excessive blood loss and reduce the duration of recovery and hospital stay. These surgeries also reduce the need for blood transfusions and the risk of infections, cause less pain and scarring, and lead to the better clinical outcome. Browse complete report @ http://www.rnrmarketresearch.com/global-vascular-stents-market-2016-2020-market-report.html.
Explore other new reports on Medical Devices Market @ http://www.rnrmarketresearch.com/reports/life-sciences/medical-devices.
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.
Connect with Us:
G+ / Google Plus: https://plus.google.com/104156468549256253075/posts
RSS / Feeds: http://www.rnrmarketresearch.com/feed
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
SOURCE RnR Market Research